N-[(1S)-1-(4-chloro-3-fluorophenyl)ethyl]-2-[4-(4-chlorophenyl)-3-hydroxy-3H-1,2,4-triazol-2-yl]acetamide
C18H17Cl2FN4O2 — CID 156528269
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S)-1-(4-chloro-3-fluorophenyl)ethyl]-2-[4-(4-chlorophenyl)-3-hydroxy-3H-1,2,4-triazol-2-yl]acetamide
N-[(1S)-1-(4-chloro-3-fluorophenyl)ethyl]-2-[4-(4-chlorophenyl)-3-hydroxy-3H-1,2,4-triazol-2-yl]acetamide (PubChem CID 156528269) has the molecular formula C18H17Cl2FN4O2 and a molecular weight of 411.26 g/mol. Its IUPAC name is N-[(1S)-1-(4-chloro-3-fluorophenyl)ethyl]-2-[4-(4-chlorophenyl)-3-hydroxy-3H-1,2,4-triazol-2-yl]acetamide.
Molecular Properties
| Compound Name | N-[(1S)-1-(4-chloro-3-fluorophenyl)ethyl]-2-[4-(4-chlorophenyl)-3-hydroxy-3H-1,2,4-triazol-2-yl]acetamide |
|---|---|
| PubChem CID | 156528269 |
| Molecular Formula | C18H17Cl2FN4O2 |
| Molecular Weight | 411.26 g/mol |
| Exact Mass | 410.07 |
| IUPAC Name | N-[(1S)-1-(4-chloro-3-fluorophenyl)ethyl]-2-[4-(4-chlorophenyl)-3-hydroxy-3H-1,2,4-triazol-2-yl]acetamide |
| SMILES | C[C@H](NC(=O)CN1N=CN(c2ccc(Cl)cc2)C1O)c1ccc(Cl)c(F)c1 |
| InChI | InChI=1S/C18H17Cl2FN4O2/c1-11(12-2-7-15(20)16(21)8-12)23-17(26)9-25-18(27)24(10-22-25)14-5-3-13(19)4-6-14/h2-8,10-11,18,27H,9H2,1H3,(H,23,26)/t11-,18?/m0/s1 |
| InChIKey | ABVMSDWWJHYXMH-FAQQKDIKSA-N |
| XLogP | 3.35 |
| TPSA | 68.17 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 411.26 |
| LogP ≤ 5 | 3.35 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156528269 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.